Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 31;10(1):74.
doi: 10.1186/s13104-017-2404-4.

Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia

Affiliations

Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia

Selam Niguse Sahle et al. BMC Res Notes. .

Abstract

Background: There are few rapid point-of-care tests (POCT) for tuberculosis (TB) for use in resource-constrained settings with high levels of human immunodeficiency virus (HIV). This hinders early tuberculosis (TB) treatment. This cross-sectional study evaluates the recently developed urine Determine tuberculosis lipoarabinomannan (TB LAM) antigen test. A total of 122 participants with signs and symptoms of TB, including 21 (17.1%) participants positive for HIV, were enrolled from September 2011 to March 2012 at three selected health centers in Addis Ababa, Ethiopia. Blood, sputum and urine samples were collected. Löwenstein-Jensen (LJ) solid culture was used as a gold standard to evaluate the performance of the Determine TB LAM antigen test. Data were analyzed using STATA (Statacorp LP, USA).

Results: Of the 122 participants with suspected TB, 35 (28.7%) had TB confirmed bacteriologically by LJ culture. The overall sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of Determine TB LAM (for both HIV-positive and HIV-negative participants) was 37.1% (95% CI 21.5-55.1), 97.7% (95% CI 91.9-99.7), 86.7% (95% CI 59.5-98.3) and 79.4% (95% CI 70.5-86.6), respectively. However, in participants who were co-infected with TB and HIV, sensitivity, specificity, PPV and NPV were 55.6% (95% CI 21.2-86.3), 100% (95% CI 73.5-100), 100% (95% CI 47.8-100) and 75.0% (95% CI 47.6-92.7). Moreover, the level of immunosuppression of the HIV-infected TB patients was found to have a significant association with the performance of Determine TB LAM (χ2 = 7.89, p = 0.002).

Conclusions: The Determine TB LAM test is a potential alternative in peripheral health settings for TB diagnosis in patients who are co-infected with HIV, with advanced immunosuppression.

Keywords: Lipoarabinomannan; Performance; Point-of-care.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Tuberculosis diagnostic flow and diagnostic results of TB suspects
Fig. 2
Fig. 2
Sensitivity and specificity of Determine TB LAM test and smear microscopy; a among HIV co-infected individuals b among HIV negative individuals

References

    1. Myers J, Sepkowitz K. HIV/AIDS and TB. Amsterdam: Elsevier; 2008. pp. 421–430.
    1. World Health Organization. Global tuberculosis report 2014. http://www.who.int/tb/publication/global_report/en/index.html. Accessed 12 Apr 2015.
    1. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P. Tuberculosis Tuberculosis 1 control and elimination 2010–50: cure, care, and social development. Lancet. 2010;375:1814–1829. doi: 10.1016/S0140-6736(10)60483-7. - DOI - PubMed
    1. Moise L, McMurry J, DeGroot AS. Mycobacterium tuberculosis. Vaccines for biodefense and emerging and neglected diseases. 2009; 1219–39.
    1. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–354. doi: 10.7326/0003-4819-146-5-200703060-00006. - DOI - PubMed